Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 14, 2023; 29(14): 2202-2221
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2202
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2202
Table 3 Meta-regression according to selected covariates
| Subgroup | Studies, n | Estimate | 95%CI | P value | I2, % |
| Year | |||||
| ≤ 2015 | 54 | - | - | - | 92.5 |
| > 2015 | 7 | 0.11 | -0.03 to 0.25 | 0.1188 | |
| Region | 92.8 | ||||
| Asian | 29 | - | - | - | |
| Western | 32 | -0.06 | -0.15 to 0.03 | 0.2145 | |
| Proportion of patients with t(11;18)(q21;q21)-positive gastric MALT lymphoma | |||||
| ≤ 30% | 7 | ||||
| > 30% | 4 | -0.40 | -0.59 to -0.22 | < 0.0001 | 88.6 |
| Risk of bias | 92.3 | ||||
| Low | 39 | - | - | - | |
| Moderate | 21 | 0.02 | -0.07 to 0.12 | 0.6190 | |
| High | 1 | -0.43 | -0.77 to -0.09 | 0.0139 | |
- Citation: Lemos FFB, Castro CT, Calmon MS, Silva Luz M, Pinheiro SLR, Faria Souza Mendes dos Santos C, Correa Santos GL, Marques HS, Delgado HA, Teixeira KN, Souza CL, Oliveira MV, Freire de Melo F. Effectiveness of Helicobacter pylori eradication in the treatment of early-stage gastric mucosa-associated lymphoid tissue lymphoma: An up-to-date meta-analysis. World J Gastroenterol 2023; 29(14): 2202-2221
- URL: https://www.wjgnet.com/1007-9327/full/v29/i14/2202.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2202